|
Orchid Pharma Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
3963.70 Cr.
|
P/BV
|
3.11
|
Book Value (Rs.)
|
251.16
|
|
52 Week High/Low (Rs.)
|
1984/604
|
FV/ML
|
10/1
|
P/E(X)
|
39.78
|
|
Bookclosure
|
09/08/2023
|
EPS (Rs.)
|
19.65
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| No. of Equity Shares (in Lacs) | 507.19 | 507.19 | 408.16 | 408.16 | 408.16 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 50.72 | 50.72 | 40.82 | 40.82 | 40.82 |
| Total Share Capital | 50.72 | 50.72 | 40.82 | 40.82 | 40.82 |
| | | | | | |
| Reserves and Surplus | 1216.57 | 1118.75 | 647.83 | 606.56 | 612.09 |
| Total Reserves and Surplus | 1216.57 | 1118.75 | 647.83 | 606.56 | 612.09 |
| Total Shareholders Funds | 1267.29 | 1169.47 | 688.65 | 647.38 | 652.91 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 131.64 | 120.43 | 148.84 | 208.17 | 427.50 |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 3.23 | 3.23 | 3.23 |
| Other Long Term Liabilities | 0.04 | 0.37 | 0.00 | 0.00 | 0.00 |
| Long Term Provisions | 3.39 | 3.63 | 12.60 | 11.01 | 11.54 |
| Total Non-Current Liabilities | 135.06 | 124.43 | 164.67 | 222.40 | 442.26 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 42.60 | 14.05 | 182.51 | 59.79 | 2.84 |
| Trade Payables | 222.09 | 229.58 | 181.79 | 167.68 | 109.95 |
| Other Current Liabilities | 18.51 | 14.27 | 4.11 | 10.30 | 25.76 |
| Short Term Provisions | 2.37 | 2.08 | 3.49 | 3.01 | 3.52 |
| Total Current Liabilities | 285.57 | 259.97 | 371.89 | 240.78 | 142.08 |
| | | | | | |
| Total Capital And Liabilities | 1687.91 | 1553.87 | 1225.21 | 1110.56 | 1237.25 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 631.92 | 619.59 | 572.71 | 583.37 | 670.08 |
| Intangible Assets | 0.79 | 0.64 | 0.39 | 0.34 | 0.37 |
| Capital Work-In-Progress | 64.49 | 16.39 | 46.46 | 9.78 | 7.43 |
| Intangible Assets Under Development | 16.22 | 14.28 | 0.00 | 0.00 | 0.00 |
| Fixed Assets | 713.42 | 650.91 | 619.56 | 593.49 | 677.88 |
| Non-Current Investments | 49.67 | 45.82 | 44.44 | 45.49 | 0.40 |
| Deferred Tax Assets [Net] | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 117.40 | 66.39 | 60.20 | 21.70 | 9.11 |
| Total Non-Current Assets | 880.60 | 763.12 | 724.20 | 660.68 | 687.40 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 15.02 |
| Inventories | 326.37 | 264.23 | 228.74 | 172.66 | 152.89 |
| Trade Receivables | 241.83 | 195.55 | 215.19 | 170.57 | 135.70 |
| Cash And Cash Equivalents | 179.63 | 266.57 | 30.63 | 8.06 | 19.91 |
| OtherCurrentAssets | 59.48 | 64.41 | 26.45 | 98.60 | 226.34 |
| Total Current Assets | 807.32 | 790.75 | 501.01 | 449.89 | 549.86 |
| | | | | | |
| Total Assets | 1687.91 | 1553.87 | 1225.21 | 1110.56 | 1237.25 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 310.53 | 87.93 | 48.71 | 24.87 | 0.19 |
| | | | | | |
| BONUS DETAILS | | | | | |
| Bonus Equity Share Capital | 7.97 | 7.97 | 7.97 | 7.97 | 7.97 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Quoted Market Value | 0.00 | 0.25 | 0.14 | 0.09 | 0.13 |
| Non-Current Investments Unquoted Book Value | 0.00 | 45.57 | 44.90 | 46.01 | 0.88 |
